Skip to content

Manage My Pain at Chronic Pain Clinics

Manage My Pain at Chronic Pain Clinics in Urban, Community, and Rural Hospitals

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04762329
Enrollment
246
Registered
2021-02-21
Start date
2018-01-08
Completion date
2020-04-08
Last updated
2025-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Keywords

Pain, Psychology, Patient Oriented Research, Quality of Life, Digital Health, Chronic Pain, Pain App, Virtual Care, mHealth, Pain Management, Chronic Disease Management, Remote Monitoring

Brief summary

The overall objective of this Early Adoption project is to gather evidence for how Managing My Pain Program (MMP), a novel digital pain management application can enable better care at home for chronic pain sufferers in the province of Ontario, Canada across 4 sites in urban, community, and rural settings

Detailed description

Chronic pain imposes a large burden on individuals and society. A patient-centric digital chronic pain management application, Managing My Pain Program (MMP) that incorporates validated questionnaires can be used to enhance communication between providers and patients and promote self-management to evaluate the extent of patient engagement with the app when used in clinical settings. The main objectives for this project is to evaluate the engagement in patients using MMP, and to assess improvements in clinical outcomes directly relevant for pain management, as measured by clinically-validated tools.

Interventions

OTHERManage My Pain (MMP) digital pain app group

To evaluate the extent of patient engagement with the Manage My Pain (MMP) digital application when used in a clinical setting

Sponsors

Ontario Centres of Excellence
CollaboratorINDUSTRY
University Health Network, Toronto
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* New patients with chronic pain conditions referred to participating sites with pain programs to adopt the MMP tool into clinical practice.

Exclusion criteria

* Patients declining to consent for the study * Patients withdrawing from the study at a later time after consenting

Design outcomes

Primary

MeasureTime frameDescription
Evaluating engagement based on adoption and retention rates24 monthsEvaluating the number of patients who elected to use the Manage My Pain (MMP) application, and determining how long they used the app in the short-term (4.5 months) and long-term (4.5-7 months) follow-ups

Secondary

MeasureTime frameDescription
Change in anxiety as measured by the General Anxiety Disorder 7-item Questionnaire (GAD-7)Short-term (4.5 months) and long-term (4.5-7 months)Minimum score of 0, maximum score of 21. The higher the score, the higher the severity of anxiety.
Change in pain disability as measured by the Pain Disability Index (PDI)Short-term (4.5 months) and long-term (4.5-7 months)Minimum score of 0, maximum score of 70. The higher the score, the higher the severity of pain disability.
Change in depression as measured by the Patient Health Questionnaire 9-item (PHQ-9)Short-term (4.5 months) and long-term (4.5-7 months)Minimum score of 0, maximum score of 27. The higher the score, the higher the severity of depression.
Change in opioid consumption as measured by Oral Morphine Equivalents (OME)Short-term (4.5 months) and long-term (4.5-7 months)Minimum amount of 0, no maximum amount. The higher the amount the more opioid they are taking
Change in patient satisfaction as measured by the Patient Global Impression of Change (PGIC) scaleShort-term (4.5 months) and long-term (4.5-7 months)Minimum score of 1, maximum score of 7. The higher the score, the higher the level of patient satisfaction.
Change in pain catastrophizing and measured by the Pain Catastrophizing Scale (PCS)Short-term (4.5 months) and long-term (4.5-7 months)Minimum score of 0, maximum score of 52. The higher the score, the higher the severity of pain catastrophizing.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026